Amanda Carey, J.D.
About Amanda Carey, J.D.
Amanda Carey, J.D., serves as the Associate Director of Corporate Strategy and Planning at Kite Pharma, where she focuses on opportunity assessments and evaluates new therapeutic modalities for business expansion. She has a background in analytical chemistry and corporate development, having previously held positions at Kite Pharma, Gilead Sciences, and Genentech.
Current Role at Kite Pharma
Amanda Carey serves as the Associate Director of Corporate Strategy and Planning at Kite Pharma, a position she has held since 2021. In this role, she prepares opportunity assessments that analyze the current and future standards of care, technical challenges, and the competitive landscape. Her work focuses on identifying potential business development opportunities to support the company's strategic goals.
Previous Experience at Kite Pharma
Prior to her current role, Amanda Carey held several positions at Kite Pharma. She was the Associate Director of Product Team Lead in Corporate Development from 2020 to 2021. Additionally, she served as Senior Manager of CMC Program Management from 2018 to 2020 and briefly as Associate Director of CMC Program Management in 2020. Her tenure at Kite Pharma has involved significant contributions to corporate development and program management.
Professional Background in Pharmaceutical Industry
Amanda Carey has a diverse background in the pharmaceutical industry. She worked as a Research Associate in the Analytical Chemistry Department at Gilead Sciences from 2010 to 2011. Earlier, she gained experience as an intern in Small Molecule Analytical Chemistry at Genentech from 2007 to 2009. These roles provided her with a solid foundation in analytical chemistry and product development.
Education and Academic Qualifications
Amanda Carey earned her Juris Doctor (J.D.) from the Maurice A. Deane School of Law at Hofstra University. She also holds an Artium Baccalaureatus in Chemistry from the University of California, Davis. Her educational background equips her with a strong understanding of both legal and scientific principles, which she applies in her current role.
Research and Evaluation Expertise
In her current position, Amanda Carey engages with external third-party consultants to conduct market research. She synthesizes information on new disease areas and advanced therapeutic modalities, such as cell therapies and mRNA cancer vaccines, to evaluate long-term business expansion opportunities. Her analytical skills contribute to informed decision-making within the corporate strategy team.